{"topic_id":"ca_hcsc_dpd_canine_antiparasitic_external","category":"canada","context":"---\ntopic_id: ca_hcsc_dpd_canine_antiparasitic_external\ncategory: canada\ntitle: CA Health Canada DPD canine external antiparasitic drugs (Marketed, 2026-07-21 scrape)\nlang: en\nsource: Health Canada DPD online query — drugClass=Veterinary, vetSpecies=Dogs (2026-07-21)\ndate_parsed: 2026-07-21\ntokens_estimated: 320\nsource_document: \"Health Canada / CFIA pet food regulations\"\ncitation:\n  authority: \"canada\"\n  title: \"CA Health Canada DPD canine external antiparasitic drugs (Marketed, 2026-07-21 scrape)\"\n  url: \"\"\n  retrieved: \"2026-07-21\"\n  ref: \"\"\n  doc_type: \"official source\"\n  needs_review: true\nauthority_tier: T1\nauthority_tier_basis: \"T1:canada-gov\"\nauthority_tier_date: 2026-08-04\n---\n\nHealth Canada's Drug Product Database (DPD) lists veterinary drug products approved for dogs. Three widely-marketed canine **external** (systemic/topical ectoparasiticide) antiparasitic products confirmed via the 2026-07-21 DPD online query (drugClass=Veterinary, vetSpecies=Dogs): (1) **Bravecto** (fluralaner chewable tablet) — 6 Marketed DINs starting at DIN 02425068 (FLURALANER 112.5 MG) plus 4 Marketed DINs of Bravecto topical solution starting at DIN 02454947 (112.5 MG / 0.4 ML); company INTERVET CANADA CORP; Schedule PRESCRIPTION; Veterinary class. (2) **NexGard** (afoxolaner chewable) — 4 Marketed DINs starting at DIN 02427435 (AFOXOLANER 11.3 MG), 28.3 MG (DIN 02427443), 68 MG (DIN 02427451), 136 MG (DIN 02427478); company BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.; Schedule PRESCRIPTION. (3) **Advantage Multi** (imidacloprid + moxidectin topical) — 4 Marketed DINs for dogs starting at DIN 02263556 (IMIDACLOPRID 40 MG / 0.4 ML); company ELANCO CANADA LIMITED; Schedule PRESCRIPTION. The full canine veterinary DPD subset contains **1,077 product rows** (HTML table) on 2026-07-21, with status distribution: Cancelled Post Market 447; Marketed 360; Dormant 140; Approved 88; Cancelled Pre Market 29; Cancelled (Unreturned Annual) 13. Across all pet veterinary subsets (Dogs + Cats + \"Dog or cat\", 1,810 raw rows, 1,312 unique DINs), the topical/systemic ectoparasiticide actives fluralaner (10 Bravecto Marketed DINs for dogs), afoxolaner (4 NexGard Marketed DINs), imidacloprid (4 Advantage Multi Marketed DINs for dogs + 2 for cats), and selamectin (32 product rows incl. Revolution) dominate the Marketed canine external antiparasitic lines.\n\nSource: https://health-products.canada.ca/dpd-bdpp/search-recherche (Health Canada DPD online query, drugClass=Veterinary, vetSpecies=Dogs, status=all), raw HTML retained at `pdf-raw/ca-2026/dpd/_raw/dpd_dogs_vet_search_20260721.html`.","sources":["canada — CA Health Canada DPD canine external antiparasitic drugs (Marketed, 2026-07-21 scrape) (retrieved 2026-07-21)"],"source":{"authority":"canada","title":"CA Health Canada DPD canine external antiparasitic drugs (Marketed, 2026-07-21 scrape)","url":"https://www.canada.ca/","retrieved":"2026-07-21","ref":"","doc_type":"official source","source_document":"Health Canada / CFIA pet food regulations","verification_file":"Health Canada DPD online query — drugClass=Veterinary, vetSpecies=Dogs (2026-07-21)"},"source_document":"Health Canada / CFIA pet food regulations","source_file":"Health Canada DPD online query — drugClass=Veterinary, vetSpecies=Dogs (2026-07-21)","trust":{"authority_tier":"T1","fidelity":"verbatim","license":null,"display_grade":"A"},"tokens_estimated":320,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}